中文版
- NEWS & EVENTS
WallabyPhenox Group Appoints James Lago as CEO to Accelerate its Global Expansion
2023-09-04
more>Renowned by Expertise and Versatility | Wallaby Medical's pNOVUS™ 17 Microcatheter has been approved in China, USA and Japan
2023-08-17
more>Wallaby Medical ranks among Top 10 Most Growing Innovative Device Enterprises
2023-07-24
more>Wallaby Medical phenox Obtained FDA 510k Clearance for its pRESET Thrombectomy Device
2023-02-06
more>Wallaby Medical Esperance™ Aspiration Catheter Approved by Ministry of Food and Drug Safety of South Korea
2022-09-09
more>Wallaby Expands Distribution Agreement With Japan Lifeline For Neurovascular Products for the Japan Market
2022-08-21
more>Wallaby Medical Launches pRESET Stentriever in Brazil
2022-08-19
more>Wallaby Medical Avenir® Plus Coil System Approved by NMPA
2022-04-23
more>Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
2022-04-21
more>Wallaby Medical Esperance™ 6F Aspiration Catheter Approved by NMPA
2022-04-02
more>Wallaby Medical launches Avenir® Coil System for hemorrhagic stroke treatment in Japan
2021-12-27
more>Wallaby Medical Obtained FDA 510k Clearance for its Esperance™ 5F & 6F Aspiration Catheter
2021-12-04
more>Wallaby Medical partners with Brainomix to bring the most comprehensive AI stroke imaging solution to China
2021-08-26
more>Wallaby Medical Avenir® Coil System Receives China NMPA Approval
2021-08-21
more>Wallaby Medical Closes Series C Funding Round
2020-11-24
more>Wallaby Medical Raises Series B+ Financing to Accelerate Development of its Innovative Stroke Solution Portfolio
2020-08-18
more>Ceremonial contract signing in Shanghai: phenox and Wallaby Medical seal strategic sales cooperation
2019-12-09
more>Wallaby Medical, Inc. announces CE Mark and FDA Clearance of the Avenir® Coil System
2019-09-17
more>
©2022 Wallaby Medical. All Rights Reserved | Privacy Statement 
Official Wechat
©2022 Wallaby Medical. All Rights Reserved
Privacy Statement
Official Wechat